Spain allows embryo selection to screen for cancer genes

April 22, 2009

Health authorities in Spain said Wednesday they had authorised the genetic screening of pre-implantation embryos to ensure they do not carry genes that might cause cancer.

Spain's National Commission for Assisted Human Reproduction on Tuesday allowed the process for two specific cases for women undergoing fertility treatment.

One of them involved screening for a gene that causes breast cancer and other for thyroid cancer.

Any daughter born with the BRCA 1 gene has an 80 per cent risk of developing breast cancer and a 60 per cent chance of developing -- as well as a 50 percent risk of passing on the anomaly to their own children.

"It is an historic day in the world of health," said secretary of state for health, Jose Martinez Olmos. He said the two decisions "bring hope" for the families faced with "major health problems."

He told private radio Cadena Ser that such decisions would be made on a "case by case" basis.

The procedure is still relatively rare in the world but has been used to screen embryos for breast cancer in Britain, the United States and Belgium.

In January, a mother in Britain became the first woman in the country to have a baby selected free of a gene which causes .

Spain's Socialist government has already angered the Roman Catholic Church with proposals to liberalise the abortion law.

In October, Catholic bishops also condemned the genetic selection of an embryo in a bid to cure a child of a crippling inherited .

(c) 2009 AFP

Related Stories

Recommended for you

Poliovirus therapy induces immune responses against cancer

September 20, 2017
An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells ...

Scientists restore tumor-fighting structure to mutated breast cancer proteins

September 20, 2017
Scientists at the Virginia Tech Carilion Research Institute have successfully determined the full architecture of the breast cancer susceptibility protein (BRCA1) for the first time. This three-dimensional information provides ...

Researchers identify new target, develop new drug for cancer therapies

September 20, 2017
Opening up a new pathway to fight cancer, researchers at the University of Pennsylvania have found a way to target an enzyme that is crucial to tumor growth while also blocking the mechanism that has made past attempts to ...

Brain cancer growth halted by absence of protein, study finds

September 20, 2017
The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain's nerve cells, according to a new study by researchers at the Stanford University School ...

New clinical trial explores combining immunotherapy and radiation for sarcoma patients

September 20, 2017
University of Maryland School of Medicine researchers are investigating a new approach to treat high-risk soft-tissue sarcomas by combining two immunotherapy drugs with radiation therapy to stimulate the immune system to ...

Targeted antibiotic use may help cure chronic myeloid leukaemia

September 19, 2017
The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

sex_doctor
not rated yet Apr 22, 2009
The gene that empties your bank account should also be surpressed.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.